Duke Radiation Oncology is proud to represent our Department during ASTRO 2023. Please see below for presentations and posters from our faculty, trainees and staff.
SATURDAY, SEPTEMBER 30
Abhishek Kumar, MD, MAS
Moderator
Session: ARRO 01 - ARRO Annual Seminar
Time: 10:00 a.m.-5:00 p.m.
Manisha Palta, MD
Speaking Up at Tumor Board: Advice for Junior Physicians
Session: ARRO 01 - ARRO Annual Seminar
Time: 10:36-10:47 a.m.
SUNDAY, OCTOBER 1
W. Robert Lee, MD, MS, MEd
6 - Long-Term Follow-Up Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Non-Inferiority Study Comparing Two Fractionation Schedules in Patients with Favorable-Risk Prostate Cancer
Session: CT 01 - Clinical Trials Session
Time: 10:00-10:10 a.m.
Pooja Karukonda, MD
115 - Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-Gastric Diseases (PROCEED): Assessment of Pathologic Response in a Prospective, Phase II Single-Arm Trial
Session: SS 04 - GI 1: Predicting the Unpredictable in Esophageal Cancer and Keeping Pancreatic SBRT on the Map
Time: 4:45-4:52 p.m.
MONDAY, OCTOBER 2
Christina Huang, MD, MS
2239 - Pretreatment Clinical Parameters Associated with Intracranial Progression Burden Following an Initial Stereotactic Radiosurgery Course in a Multi-Institutional Brain Metastases Cohort
Session: PQA 02 - Poster Q&A 02 - Central Nervous System and Palliative Care
Time: 10:45 a.m.-12:00 p.m.
Jim Leng, MD
2276 - Clinical Outcomes Following an Initial Stereotactic Radiosurgery Course for Brain Metastases from Melanoma
Session: PQA 02 - Poster Q&A 02 - Central Nervous System and Palliative Care
Time: 10:45 a.m.-12:00 p.m.
Jamiluddin Qazi, MD
2314 - Multi-Institutional Outcomes Following Stereotactic Radiosurgery for Gastrointestinal Brain Metastases
Session: PQA 02 - Poster Q&A 02 - Central Nervous System and Palliative Care
Time: 10:45 a.m.-12:00 p.m.
Sarah Stephens, MD
SS 15 - Breast 2: Toxicity
Session: Breast Cancer
Time: 5:00-6:00 p.m.
TUESDAY, OCTOBER 3
John Hillson, OCN, BSN, RN, DNP
2860 - A Needs Assessment Exploring Radiation Oncology Nursing Confidence in Caring for Patients with Acute and Late Radiation Therapy Effects
Session: PQA 06 - Poster Q&A 06 - Genitourinary Cancer, Patient Safety, and Nursing
Time: 2:30-3:45 p.m.
Scarlett Acklin, MD
1130 - Novel Role of Glycogen Synthase Kinase-3ß in Determining Cancer Cell Response to Genotoxic Stress through Regulation of 53BP1 Function
Session: QP 12 - Bio 6: Tumor and Radiation Biology
Time: 4:30-4:35 p.m.
Diandra Ayala-Peacock, MD
3099 - Real-Time Precision Needle Tracking for Gynecological Interstitial Brachytherapy: A Phantom Feasibility Study
Session: PQA 08 - Poster Q&A 08 - Gynecological Cancer, Pediatric Cancer, and Professional Development
Time: 5:15-6:15 p.m.
Junzo Chino, MD
3126 - A Multi-Institutional Analysis of MRI-Based Brachytherapy for Medically Inoperable Endometrial Cancer
Session: PQA 08 - Poster Q&A 08 - Gynecological Cancer, Pediatric Cancer, and Professional Development
Time: 5:15-6:15 p.m.
Christina Huang, MD, MS
3134 - Clinical Outcomes of Sidewall/Parametrial Simultaneous Integrated Boost for Patients with Cervical Cancer
Session: PQA 08 - Poster Q&A 08 - Gynecological Cancer, Pediatric Cancer, and Professional Development
Time: 5:15-6:15 p.m.
WEDNESDAY, OCTOBER 4
Christopher Kelsey, MD
1210 - Acute Pulmonary Toxicity after Allogeneic Stem Cell Transplantation Using Total Body Irradiation-Based Conditioning- Myeloablative vs. Non-Myeloablative Regimens
Session: QP 19 - Heme 3: Every organ, every target, all at once: Modernizing Total Body Irradiation
Time: 8:15-8:20 a.m.
Pranalee Patel, MD, BS
1216 - Long-Term Toxicity after Total Body Irradiation-Based Conditioning Regimens for Allogeneic Stem Cell Transplantation
Session: QP 19 - Heme 3: Every organ, every target, all at once: Modernizing Total Body Irradiation
Time: 8:30-8:35 a.m.
Rachel Shenker, MD
3364 - Environmental Toxicity of Driving Distance to External Beam Radiotherapy (EBRT) for Head and Neck Cancer Patients
Session: PQA 09 - Poster Q&A 09 - Head & Neck Cancer and Health Services Research
Time: 10:30-11:45 a.m.
Eugene Vaios, MD, MBA
1254 - Intracranial Control with Combined Dual Immune-Checkpoint Blockade and SRS for Melanoma and NSCLC Brain Metastases
Session: QP 23 - CNS 3: Novel Therapies and New Considerations in CNS Radiotherapy
Time: 12:35-12:40 p.m.
Yang Sheng, PhD
3570 - Automatic Treatment Planning for Multi-focal Dynamic Conformal Arc GRID Therapy for Late Stage Lung Cancer: A Feasibility Study
Session: PQA 10 - Poster Q&A 10 - Physics
Time: 12:30-1:45 p.m.
Peter Hendrickson, MD, PhD
301 - Genetically Engineered Mouse Models of CIC-DUX4 Sarcoma Reveal an Unexpected Sensitivity to Histone Deacetylase (HDAC) Inhibition
Session: SS 35 - Biology 9: Experimental Therapeutics and Target Discovery
Time: 1:00-1:07 p.m.